This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Alpha glucosidase inhibitors

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Alpha-glucosidase inhibitors are a new class of drugs used in the treatment of non-insulin-dependent diabetes mellitus (NIDDM).

  • acts by reversible inhibition of the gastrointestinal sucrase, glucoamylase, dextrinase, maltase and isomaltase enzymes. These normally convert dietary starch and sucrose into absorbable monosaccharides. Enzyme inhibition therefore delays and reduces the peak of postprandial blood glucose
  • an example of an alpha-glucosidase inhibitor is Acarbose
  • a systematic review concerning alpha-glucosidase inhibitors concluded that (2):
    • it is unclear whether alpha-glucosidase inhibitors influence mortality or morbidity in patients with type 2 diabetes
    • these agents have a significant effect on glycemic control and insulin levels, but no statistically significant effect on lipids and body weight. However these effects are less sure when alpha-glucosidase inhibitors are used for a longer duration
    • acarbose dosages higher than 50 mg TDS offer no additional effect on glycated hemoglobin but more adverse effects instead
    • compared to sulphonylurea, alpha-glucosidase inhibitors lower fasting and post-load insulin levels and have an inferior profile regarding glycemic control and adverse effects

Reference:

  1. Drug and Therapeutics Bulletin 1999; 37 (11): 84-87.
  2. van de Laar FA et al. Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. Diabetes Care 2005;28:154-63

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.